1. Prevention of iron loading in transfusion-dependent thalassaemia;Pippard, M.J.; Latsky, E.A.; Callender, S.T.; Weatheral, D.J.;Lancet,1977
2. Reassessment ofthe use of desferrioxaamine B in iron overload;Propper, R.D.; Shurin, S.B.; Nathan, D.G.;N Engl J Med; 29: great difference in the pattern and flash ERG results which, from the patients' point of view, are very similar. Those patients who seemed recalcitrant were not those who necessarily had poor results,1976
3. Ferrioxamine excretion in iron loaded man;Pippard, M.J.; CaUender, S.T.; Finch, C.A.;Blood,1982
4. Improvement in iron status and liver function with chronic subcutaneous des- In the case of funduscopy it is most likely that the incidence of tortuous vessels is related to changes which occur early in life'4 before treatment, and there is only a poor correlation between the presence of ferrioxamine therapy;Hoffbrand, A.V.; Gorman, A.; Laulicht, M.; et at;Lancet,1979
5. Ocular toxicity of high-dose intravenous desferioxamine;Davies, S.C.; Hungerford, J.L.; Arden, G.B.; Marcus, R.E.; Miller, M.H.; Huehns, E.R.;Licet